A Multicenter, Retrospective study to evaluate the efficacy and safety of secukinumab dose optimization in patients with Psoriasis
Latest Information Update: 09 May 2018
At a glance
- Drugs Secukinumab (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 09 May 2018 New trial record